We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $168M
1-Year Est. Return 60.36%
This Fund
S&P 500
This Quarter Est. Return
+14.01%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
10 Year Est. Return
AUM
$295M
AUM Growth
Cap. Flow
+$270M
Cap. Flow %
91.73%
Top 10 Hldgs %
52.03%
Holding
133
New
133
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 25.39%
2 Healthcare 22.79%
3 Materials 19.04%
4 Communication Services 6.12%
5 Real Estate 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KAIR
26
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$3.38M 1.15%
+345,463
New +$3.38M
INCY icon
27
Incyte
INCY
$23.4B
$3.14M 1.07%
+42,820
New +$2.89M
JAZZ icon
28
Jazz Pharmaceuticals
JAZZ
$15.5B
$2.98M 1.01%
+23,411
New +$3.08M
GREE
29
Greenidge Generation Holdings
GREE
$30.8M
$2.97M 1.01%
+18,506
New +$3.88M
GLHAW
30
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
$2.88M 0.98%
+250,000
New +$164K
XENE icon
31
Xenon Pharmaceuticals
XENE
$6.6B
$2.7M 0.92%
+86,488
New +$2.58M
BMY icon
32
Bristol-Myers Squibb
BMY
$124B
$2.64M 0.9%
+42,409
New +$2.49M
AB icon
33
AllianceBernstein
AB
$3.54B
$2.47M 0.84%
+50,500
New +$2.64M
ZGNX
34
DELISTED
Zogenix, Inc.
ZGNX
$2.19M 0.74%
+134,688
New +$1.97M
AVDL
35
DELISTED
Avadel Pharmaceuticals
AVDL
$2.09M 0.71%
+258,198
New +$2.36M
HZNP
36
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.05M 0.69%
+19,000
New +$2.07M
JPM icon
37
JPMorgan Chase
JPM
$907B
$2.05M 0.69%
+12,920
New +$2.12M
INVA icon
38
Innoviva
INVA
$1.6B
$1.99M 0.67%
+115,269
New +$1.96M
PMGM
39
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$1.98M 0.67%
+200,000
New +$1.97M
TWLVW
40
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.98M 0.67%
+171,666
New +$108K
DNMR
41
DELISTED
Danimer Scientific, Inc.
DNMR
$1.7M 0.58%
+5,000
New +$2.75M
KAIRW
42
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1.69M 0.57%
+146,528
New +$85.6K
EIGR
43
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.65M 0.56%
+10,583
New +$2.05M
CHRS icon
44
Coherus Oncology
CHRS
$216M
$1.64M 0.56%
+102,555
New +$1.79M
ABBV icon
45
AbbVie
ABBV
$450B
$1.35M 0.46%
+10,000
New +$1.18M
BRIVW
46
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$1.34M 0.46%
+116,666
New +$120K
PMGMW
47
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$1.15M 0.39%
+100,000
New +$62.7K
RHP icon
48
Ryman Hospitality Properties
RHP
$7.99B
$1.14M 0.39%
+12,400
New +$1.06M
MDLZ icon
49
Mondelez International
MDLZ
$78.3B
$995K 0.34%
+15,000
New +$926K
QTEK
50
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$992K 0.34%
+100,000
New +$993K

Similar funds

David M. Knott Jr's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for David M. Knott Jr, which disclosed 133 positions worth $295M. Its ten largest holdings account for 52% of the portfolio.

Its largest position is Calumet Specialty Products: 3,952,000 shares worth $52.2M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, followed by Healthcare and Materials.

  • David M. Knott Jr's largest Q4 2021 buy was Calumet Specialty Products: 3,952,000 shares worth $52.2M.
  • David M. Knott Jr's ten largest holdings make up 52% of its $295M portfolio in Q4 2021.
  • David M. Knott Jr disclosed 133 positions in Q4 2021, its first 13F filing on record.

Based on David M. Knott Jr's 13F filing for Q4 2021, filed 11 Feb 2022.